In case you missed it: April 12 to April 16
It was a very busy week for the Contemporary Pediatrics team.
This week’s top articles included:
Using vitamin D to mitigate risk of childhood asthma in offspring of mothers with asthma
Maternal asthma is a major risk factor for a child also developing asthma. A report examines whether vitamin D sufficiency in pregnancy can change that risk.
HPV vaccine in pregnancy not linked to adverse birth outcomes
It’s not common, but some women may have been given the 9-valent human papillomavirus (HPV) vaccine either during or before pregnancy. A study examines the effect of such exposure on adverse birth outcomes.
Pandemic offers insight into potential cause of Kawasaki disease
Given the high prevalence of Kawasaki disease during the pandemic, Japanese investigators determined that droplet or contact transmission of pathogens is likely not a major route causing the development of the disease.
Analysis of COVID-19 clinical trials: A guide to reducing vaccine hesitancy
Tackling vaccine hesitancy for the coronavirus disease 2019 (COVID-19) is going to be an important component of achieving the herd immunity needed to end the pandemic.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
